Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: A biobehavioral pathway to coronary artery disease?

Psychosomatic Medicine

Volumn 63, Issue 4, 2001, Pages 531-544

  Von Känel, Roland ^b   Mills, Paul J ^a   Fainman, Claudia ^a   Dimsdale, Joel E ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood coagulation; Depressive disorder; Fibrinolysis; Hemostasis; Personality; Psychological stress

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ANXIETY NEUROSIS; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE COURSE; EMOTIONAL STRESS; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; HYPERCOAGULABILITY; JOB SATISFACTION; MENTAL DISEASE; MENTAL STRESS; NORMAL HUMAN; PRIORITY JOURNAL; SOCIOECONOMICS; THROMBOSIS;

EID: 0034928695     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-200107000-00003     Document Type: Article

References (147)

1. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy
2. Mental stress as a trigger of myocardial ischemia and infarction
3. Current issues relating to psychological job strain and cardiovascular disease research
4. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease
5. Socioeconomic factors and cardiovascular disease: A review of the literature
6. Refining, the type A hypothesis: Emergence of the hostility complex
7. A perspective on type A behavior and coronary disease
8. A systematic review of the mortality of depression
9. Psychosocial factors in the aetiology and prognosis of coronary heart disease: Systematic review of prospective cohort studies
10. Anxiety and coronary heart disease: A synthesis of epidemiological, psychological, and experimental evidence
11. The contribution of thrombosis to the clinical expression of coronary atherosclerosis
12. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions
13. Conner memorial lecture. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
14. Platelets and coronary artery disease: Potential psychophysiologic mechanisms
15. Platelets and psychiatry: Lessons learned from old and new studies
16. The relationsip of depression to cardiovascular disease. Epidemiology, biology, and treatment
17. Coagulation cascade: An overview
18. Newer concepts of blood coagulation
19. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
20. Mechanisms of platelet activation
21. Platelet membranes and receptors
22. Von Willebrand factor: Structure and function
23. Thrombosis and fibrinolysis
24. Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasma
25. The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation
26. Thromboembolic diseases: Biochemical mechanisms and new possibilities of biological diagnosis
27. The haemostatic balance - Astrup revisited
28. Hemostatic factors as triggers of cardiovascular events
29. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
30. Haemostatic risk factors for cardiovascular diseases
31. Fibrinogen and risk of cardiovascular disease. The Framingham Study
32. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
33. Haemostatic variables and the outcome of myocardial infarction
34. Factor VIII, ABO blood group and the incidence of ischaemic heart disease
35. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: Evidence for the fibrinolytic system as an independent primary risk factor
36. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
37. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
38. Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study
39. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study
40. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study
41. A selective depression of tissue plasminogen activator (t-PA) activity in euglobulins characterises a risk group among survivors of acute myocardial infarction
42. Antithrombin III and arterial disease
43. Antithrombin and atherosclerosis in the Rotterdam Study
44. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes
45. Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease
46. Treatment of unstable angina: Role of antithrombotic therapy
47. Factors affecting the coagulation time of blood. IV. The hastening of coagulation in pain and emotional excitement
48. Observations on fibrinolysis: Spontaneous activity associated with surgical operations, trauma etc
49. Anxiety as a cause of fibrinolysis
50. Fibrinolysis and the eosinophil count
51. The influence of anxiety in tests of blood coagulability and fibrinolytic activity
52. Coagulation time of the blood, level of blood eosinophils and thrombocytes under emotional stress
53. Influence of some drugs and of emotions on blood coagulation
54. Changes in blood clotting time and blood sugar levels in relation to electroshock therapy
55. The influence of autonomic arousal on blood clotting time in patients receiving electroconvulsive treatments
56. The lability of human fibrinolysis
57. Studies on enhanced fibrinolytic activity in man
58. Changes of parameters in fibrinolytic system caused by mental stress
59. Changes of plasma coagulation and fibrinolysis in response to mental stress
60. Hemostatic response to mental stress during the menstrual cycle
61. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women
62. Effects of acute psychological stress on serum lipid levels, hemoconcentration, and blood viscosity
63. Fibrinolisi e cold-pressor-test
64. Cardiovascular reactivity, plasma markers of endothelial and platelet activity and plasma renin activity after mental stress in normals and hypertensives
65. Influence of metoprolol treatment on sympatho-adrenal activation of fibrinolysis
66. Decreased fibrinolytic response to adrenergic stimulation in hypertensive patients
67. Earthquake-induced potentiation of acute risk factors in hypertensive elderly patients: Possible triggering of cardiovascular events after a major earthquake
68. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII
69. Stress-induced hemodynamic and hemostatic changes in patients with systemic hypertension: Effect of verapamil
70. Is there a hypercoagulable state in military fighter pilots?
71. Activation of haemostasis by exercise, mental stress and adrenaline: Effects on platelet sensitivity to thrombin and thrombin generation
72. Hemostatic activation and cardiac events after the 1995 Hanshin-Awaji earthquake
73. Platelet and clotting activities after cold stress in diabetic patients
74. Endothelial cells in physiology and in the pathophysiology of vascular disorders
75. Anticoagulant properties of the vascular endothelium
76. Acquired defects of fibrinolysis associated with thrombosis
77. Antithrombin III biological activity and emotional stress in patients with coronary artery disease
78. Effect of mental stress on platelet function in normal subjects and in patients with coronary artery disease
79. Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension
80. The relationship between trait hostility and cardiovascular reactivity: A quantitative review and analysis
81. Association of specific overt behavior pattern with blood and cardiovascular findings
82. Work stress and metabolic and hemostatic risk factors
83. Psychosocial stress and the insulin resistance syndrome
84. Plasma fibrinogen: Levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study
85. Variations in clotting time, relative viscosity, and other physiochemical properties of the blood accompanying physical and emotional stress in the normal and hypertensive subject
86. Recurrent thrombophlebitis: An experimental study of life situations and emotions and the clotting time and relative viscosity of the blood
87. Effect of psycho-emotional stress test on the blood coagulation system and thrombocytic hemostasis in patients with stenocardia
88. Reactivity of the hemostasis system depending on the behavior model and personality features of patients with hypertensive disease under conditions of emotional stress
89. Psychological stress and neuroendocrine function in humans: The last two decades of research
90. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo
91. Nonselective β blockade attenuates the recruitment of CD62LT lymphocytes following exercise
92. The pathogenesis of atherosclerosis: A perspective for the 1990s
93. Endothelial-leukocyte adhesion molecules
94. Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106)
95. Thrombin hypothesis of thrombus generation and vascular lesion formation
96. Fibrin induction of ICAM-1 expression in human vascular endothelial cells
97. Changes in the serum cholesterol and blood clotting time in men subjected to cyclic variation of occupational stress
98. Association of chronic stress with plasminogen activator inhibitor-1 in healthy middle-aged men
99. Relationship of blood coagulation and fibrinolysis to vital exhaustion
100. Experimentally induced stress in man: Effects on blood coagulation and fibrinolysis
101. Socioeconomic status and determinants of hemostatic function in healthy women
102. Association between job characteristics and plasma fibrinogen in a normal working population: A cross sectional analysis in referents of the SHEEP Study. Stockholm heart epidemiology program
103. Changes in hemostatic function at times of cyclic variation in occupational stress
104. Chronic work stress is associated with atherogenic lipids and elevated fibrinogen in middle-aged men
105. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen
106. Are job characteristics related to fibrinogen levels in middle-aged women?
107. Fibrinogen: A possible link between social class and coronary heart disease
108. Relationship between job stress and plasma fibrinolytic activity in male Japanese workers
109. High effort, low reward, and cardiovascular risk factors in employed Swedish men and women: Baseline results from the WOLF Study
110. Plasma fibrinogen and ischemic heart disease risk factors
111. Job strain and cardiovascular risk factors: A cross sectional study of employed Danish men and women
112. The effect of psychosocial stress and risk factors for ischaemic heart disease on the plasma fibrinogen concentration
113. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men
114. Haemostatic and other cardiovascular risk factors, and socioeconomic status among middle-aged Finnish men and women
115. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study
116. Gender and employment grade differences in blood cholesterol, apolipoproteins and haemostatic factors in the Whitehall II study
117. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors
118. Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study
119. Haemostatic and other risk factors for ischaemic heart disease and social class: Evidence from the Caerphilly and Speedwell studies
120. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease
121. Relation of fetal and infant growth to plasma fibrinogen and factor VII concentrations in adult life
122. Association of negative and positive social ties with fibrinogen levels in young women
123. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations
124. Blood fibrinolytic activity, social class and habitual physical activity - II. A study of black and white men in Southern Georgia
125. Emotional, behavioral, and physiological effects of chronic stress at Three Mile Island
126. Adrenal cortical response to stress at Three Mile Island
127. Chronic stress and sympathetic-adrenal medullary responsiveness
128. Influence of metoprolol CR/ZOK on plasminogen activator inhibitor (PAI-1) in man: A pilot study
129. Plasma catecholamine and lymphocyte beta 2-adrenergic receptor alterations in elderly Alzheimer caregivers under stress
130. Effect of mental stress on the fibrinolytic reactivity to exercise
131. Blood clotting in patients with mental diseases before and after treatment
132. Effect of stress and anxiety on thrombus formation and blood viscosity factors
133. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs
134. Blood coagulation and platelet aggregation in major depression
135. Association of interleukin-6 and other biologic variables with depression in older people living in the community
136. Fibrinolytic activity in depression and neurosis
137. Sympathetic nervous system activity in major depression. Basal and desipramine-induced alterations in plasma norepinephrine kinetics
138. Depression and endocrine disorders: Focus on the thyroid and adrenal system
139. Plasma levels of arginine vasopressin elevated in patients with major depression
140. Serotonergic dysfunction in depression
141. Desmopressin - A haemostatic drug: State-of-the-art review
142. Effect of glucocorticosteroids on some coagulation tests
143. Effect of prednisolone on the coagulation and fibrinolytic systems
144. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome
145. The fibrinolytic potential in patients with Cushing's disease: A clue to their hypercoagulable state
146. Relationships between serum lipids, serotonin, platelet aggregation and some fibrinolytic parameters in humans
147. Depression and coronary heart disease: Observations and questions